dacarbazine has been researched along with Neutropenia in 79 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.27) | 18.7374 |
| 1990's | 15 (18.99) | 18.2507 |
| 2000's | 37 (46.84) | 29.6817 |
| 2010's | 21 (26.58) | 24.3611 |
| 2020's | 5 (6.33) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, GH; Wang, BC; Xiao, BY | 1 |
| Garzio, K; Grossman, S; Holdhoff, M; McElroy, K; Ozer, B; Yankulina, O | 1 |
| Abramson, JS; Armand, P; Barnes, JA; Bello, CM; Bengston, E; Jacobsen, E; LaCasce, AS; Lansigan, F; Martignetti, R; Metzler, S; Patterson, V; Redd, R; Shah, B; Sokol, L; Takvorian, T; Turba, E | 1 |
| Altuntaş, F; Bakırtaş, M; Başçı, S; Batgi, H; Çakar, MK; Dal, MS; Darçın, T; İskender, D; Merdin, A; Mert, D; Şahin, D; Tetik, A; Ulu, BU; Yiğenoğlu, TN; Yıldız, J | 1 |
| Ansell, SM; Connors, JM; Dlugosz-Danecka, M; Evens, AM; Feldman, T; Fenton, K; Forero-Torres, A; Gallamini, A; Gautam, A; Grigg, A; Jolin, H; Kim, WS; Liu, R; Oki, Y; Pocock, C; Radford, J; Savage, KJ; Tuscano, J; Younes, A | 1 |
| Hama, S; Kawamata, T; Kurisu, K; Muragaki, Y; Nosaka, R; Saito, T; Sugiyama, K; Takayasu, T; Yamasaki, F | 1 |
| Alekseev, S; Ansell, SM; Bartlett, NL; Chen, R; Connors, JM; Cunningham, D; Feldman, T; Gallamini, A; Huebner, D; Illés, Á; Jolin, HA; Josephson, NC; Jurczak, W; Kim, WS; Lech-Maranda, E; Liu, R; Oki, Y; Picardi, M; Radford, J; Ramchandren, R; Rosta, A; Sachs, J; Savage, KJ; Smolewski, P; Song, E; Straus, DJ; Walewski, J; Younes, A; Zinzani, PL | 1 |
| Ahern, C; Ames, MM; Blaney, SM; Fouladi, M; Gilbertson, RJ; Horton, T; Hummel, TR; Ingle, AM; McGovern, RM; Reid, JM; Wagner, L; Weigel, B | 1 |
| Gupta, T; Jalali, R; Mohanty, S; Moiyadi, A | 1 |
| Brennan, M; Garcon, MC; Kaley, K; Rodriguez, G; Rodriguez, T; Saif, MW | 1 |
| Ansell, SM; Connors, JM; Fanale, M; Huebner, D; Hunder, NN; O'Meara, MM; Park, SI; Younes, A | 1 |
| Bai, B; Cai, QC; Cai, QQ; Gao, Y; Huang, HQ; Jiang, WQ; Wang, XX; Xia, YF; Xia, ZJ | 1 |
| Chamberlain, MC; Cloughesy, T; Desjardins, A; Glantz, M; Mikkelsen, T; Reardon, DA; Schiff, D; Wen, PY | 1 |
| Fersht, N; Mandeville, HC; Mycroft, J; O'Leary, B; Saran, F; Solda, F; Vaidya, S; Zacharoulis, S | 1 |
| Nangalia, J; Smith, H; Wimperis, JZ | 1 |
| Bedikian, AY; Camacho, LH; Frost, AM; Hernandez, IM; Hwu, P; Hwu, WJ; Jack, MA; Kim, KB; Ng, C; Papadopoulos, NE | 1 |
| Armstrong, TS; Bondy, M; Cao, Y; Gilbert, MR; Manning, R; Okcu, MF; Scheurer, ME; Vera-Bolaños, E; Zhou, R | 1 |
| Hop, WC; Jeurissen, FJ; Roon, K; Taphoorn, MJ; Vecht, CJ; Zwinkels, H | 1 |
| Abdi, E; Beith, J; Corrie, PG; Kefford, RF; Kotasek, D; Margison, GP; Middleton, MR; Mortimer, P; Palmer, C; Ranson, M; Thomas, NP; Watson, AJ | 1 |
| Hwu, WJ; Patel, SP; Trinh, VA | 1 |
| Casey, DA; Chou, AJ; Merchant, MS; Merola, PR; Meyers, PA; Price, AP; Wexler, LH | 1 |
| Batchelor, TT; Ciampa, A; Doherty, LM; Drappatz, J; Gerard, M; Kesari, S; Lafrankie, DC; Ligon, KL; Muzikansky, A; Norden, AD; Phan, P; Sceppa, C; Schiff, D; Weiss, SE; Wen, PY; Wong, ET; Young, G | 1 |
| Culakova, E; Lyman, GH; Pettengell, R; Schwenkglenks, M; Szucs, TD | 1 |
| Burke, W; Califano, R; Carmichael, J; Gore, M; Greystoke, A; Khan, OA; Larkin, J; Lorigan, P; Margison, GP; McGown, G; Middleton, MR; Stone, J; Thorncroft, M; Watson, AJ; Wellman, S | 1 |
| Chen, ZP; Jiang, XB; Mu, YG; Sai, K; Shen, D; Yang, QY; Zhang, XH | 1 |
| Bhagirath, V; Chin-Yee, BH; Chin-Yee, IH; Lazo-Langner, A; Mangel, JE; Minuk, LA; Monkman, K | 1 |
| Arcella, A; Caporello, P; De Sanctis, V; Enrici, RM; Giangaspero, F; Lanzetta, G; Minniti, G; Salvati, M; Scaringi, C | 1 |
| Grigg, A; Ho, P; Sherman, P | 1 |
| Ambinder, RF; Gladstone, DE; Gocke, CD; Habermann, TM; Herman, JM; Jacene, HA; Jones, RJ; Kasamon, YL; Link, BK; Matsui, WH; Perkins, B; Popplewell, LL; Swinnen, LJ | 1 |
| Coan, A; Desjardins, A; Friedman, HS; Gururangan, S; Herndon, JE; Janney, D; Lipp, ES; McLendon, R; Peters, KB; Reardon, DA; Rich, JN; Sathornsumetee, S; Vredenburgh, JJ | 1 |
| Chuang, HH; Copeland, AR; Dabaja, BS; Dang, N; Fanale, MA; Fayad, LE; Feng, L; Goy, A; Hagemeister, F; Kwak, LW; Macapinlac, HA; McLaughlin, P; Neelapu, SS; Oki, Y; Pro, B; Rodriguez, MA; Romaguera, J; Samaniego, F; Younes, A; Yuan, Y | 1 |
| Dervisis, NG; Gagnon, J; Kitchell, BE | 1 |
| Advani, R; Bartlett, NL; Blum, KA; Cheson, BD; Connors, JM; Fisher, RI; Friedberg, JW; Gascoyne, RD; Gordon, LI; Gospodarowicz, M; Habermann, TM; Hong, F; Hoppe, RT; Horning, SJ; Kahl, BS; Stiff, PJ; Tuscano, JM; Wagner, H | 1 |
| Agarwala, SS; Kirkwood, JM | 1 |
| Barone, C; Caldarelli, M; Cefalo, G; Garrè, ML; Lazzareschi, I; Madon, E; Maira, G; Massimino, M; Mastrangelo, S; Mazzarella, G; Riccardi, A; Riccardi, R; Ridola, V; Ruggiero, A; Sandri, A | 1 |
| Buchheidt, D; Hofheinz, R; Hummel, M | 1 |
| Baker, SD; Batra, VK; Cutler, DL; Donehower, RC; Rudek, MA; Statkevich, P | 1 |
| Awada, A; de Valeriola, D; Dubuisson, M; Gil, T; Klastersky, J; Moerman, C; Piccart, MJ; Sales, F; Vereecken, P | 1 |
| Ahmed, T; Lerner, R; Liu, D; Nelson, J; Seiter, K; Siddiqui, AD | 1 |
| Boddy, AV; Calvert, AH; Curtin, NJ; Harris, AL; Hickson, I; Jones, C; Margison, GP; McGown, G; McHugh, P; Middleton, MR; Newell, DR; Olsen, A; Plummer, ER; Thorncroft, M; Watson, AJ | 1 |
| Di Lauro, V; Freschi, A; La Mura, N; Nigri, P; Scalone, S; Veronesi, A; Zanetti, M | 1 |
| Abate, ME; Attinà, G; Caldarelli, M; Cefalo, G; Clerico, A; Colosimo, C; Di Rocco, C; Garré, ML; Lazzareschi, I; Madon, E; Massimino, M; Maurizi, P; Mazzarella, G; Riccardi, R; Ridola, V; Ruggiero, A; Sandri, A | 1 |
| Baldacci, E; Capria, S; de Propris, MS; Meloni, G; Petrucci, MT; Pulsoni, A; Ribersani, M | 1 |
| Abrey, LE; Demopoulos, A; Malkin, MG; Omuro, AM; Raizer, JJ | 1 |
| Chand, VK; Link, BK; Ritchie, JM; Shannon, M; Wooldridge, JE | 1 |
| Console, G; Iacopino, P; Irrera, G; Martino, M; Massara, E; Messina, G; Praticò, G | 1 |
| Geng, Y; Li, EX; Li, SM; Shang, JT; Shi, F; Wu, YY; Xu, Z; Zhang, YT | 1 |
| Fayad, L; Goy, A; Pro, B; Romaguera, J; Wang, M; Younes, A | 1 |
| Gerber, DE; Grossman, SA; Kleinberg, L; Parisi, MA; Zeltzman, M | 1 |
| Bate, SC; Beirne, DA; Eisen, TG; Gibbens, IM; Gore, ME; Hughes, SA; Larkin, JM; Patel, PM; Thomas, K | 1 |
| Chen, ZP; Mu, YG; Sai, K; Shi, HL; Yue, WY; Zhang, JP; Zhang, XH | 1 |
| Gijtenbeek, JM; Kappelle, AC; Soetekouw, PM; van der Maazen, RW; van Herpen, CM | 1 |
| Bartlett, NL; Canellos, GP; Cheson, BD; Friedberg, JW; Johnson, JL; Johnson, KB; Niedzwiecki, D; van Besien, K; Zelenetz, AD | 1 |
| Brown, MP; Selva-Nayagam, S; Singhal, N | 1 |
| Filatova, LV; Gershanovich, ML | 1 |
| Bratta, M; Candeloro, G; Fumagalli, L; Necozione, S; Rea, S; Recchia, F | 1 |
| Kennealey, GT; Kirkwood, JM; Luikart, SD | 1 |
| Baccarani, M; Barillari, G; Fanin, R; Russo, D; Silvestri, F; Velisig, M; Virgolini, L; Zaja, F | 1 |
| Antoine, E; Brain, E; Fontaine, F; Genin, J; Janin, N; Kayitalire, L; Le Cesne, A; Le Chevalier, T; Spielmann, M; Toussaint, C | 1 |
| Aulitzky, WE; Bemb, W; Huber, C; Kolbe, K; Peschel, C; Schönbohn, H; Schuler, M | 1 |
| Bonichon, F; Bui, BN; Chevallier, B; Chevreau, C; Cupissol, D; Fargeot, P; Krakowski, I; Maugard-Louboutin, C; Peny, AM; Thyss, A | 1 |
| Dolan, ME; Janisch, L; Mitchell, RB; Ratain, MJ; Schilsky, RL; Vogelzang, NJ | 1 |
| Lee, SM; Margison, GP; Thatcher, N; Woodcock, AA | 1 |
| Bengala, C; Conte, P; Giannessi, P; Michelotti, A; Romanini, A | 1 |
| Clarke, K; Grigg, A | 1 |
| García Sanz, R; Ramos Ortega, FJ; Rodríguez García, J; Sandoval Guerra, V | 1 |
| Berk, T; Blackstein, M; Cohen, Z; Gallinger, S; Madlensky, L; McLeod, R; Schnitzler, M | 1 |
| Gustavsson, A | 1 |
| Losardo, P; Pensa, F; Pronzato, P; Tognoni, A | 1 |
| Agarwala, SS; Baker, SD; Barrington, R; Britten, CD; Diab, SG; Eckardt, JR; Eckhardt, SG; Fraass, U; Hammond, LA; Johnson, T; Rowinsky, EK; Statkevich, P; Villalona-Calero, M; Von Hoff, DD | 1 |
| Baker, SD; Dugan, M; Eckardt, JR; Eckhardt, SG; Forral, K; Hammond, LA; Reidenberg, P; Rinaldi, DA; Rowinsky, EK; Statkevich, P; Von Hoff, DD; Weiss, GR | 1 |
| Avishay, AE; Kitay-Cohen, Y; Lishner, M; Manor, Y | 1 |
| Aglietta, M; Amadori, S; Botto, B; Cantonetti, M; Castoldi, GL; Dammacco, F; Fagioli, F; Ferrara, R; Levis, A; Montemurro, F; Racanelli, V; Teofili, L; Volta, C | 1 |
| Allen, J; Becker, M; Gibbs, P; Gonzalez, R; Iannucci, A; McDowell, K; Murphy, J; O'Driscoll, M; Rosse, P; Williams, P | 1 |
| Ascierto, PA; Cellerino, R; Comella, G; Comella, P; Daponte, A; DeLena, M; Gravina, A; Marini, G; Melucci, MT; Palmieri, G | 1 |
| Affrime, MB; Batra, VK; Cutler, DL; Hajian, G; Heft, S; Jen, JF; Pai, SM; Zambas, DN | 1 |
| Gerson, SL; Haaga, J; Liu, L; Majka, S; Spiro, TP; Willson, JK | 1 |
| Bafaloukos, D; Briassoulis, E; Fountzilas, G; Georgoulias, V; Gogas, H; Kalofonos, Ch; Karabelis, A; Kosmidis, P; Samantas, E; Skarlos, D | 1 |
| Babović, N; Jelić, S; Kreacić, M; Matković, S; Popov, I; Stamatović, L | 1 |
2 review(s) available for dacarbazine and Neutropenia
| Article | Year |
|---|---|
The safety of temozolomide in the treatment of malignancies.
Topics: Antineoplastic Agents, Alkylating; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Humans; Lymphopenia; Nausea; Neoplasms; Neutropenia; Radiotherapy; Temozolomide; Thrombocytopenia; Vomiting | 2009 |
Prolonged and severe myelosuppression in two patients after low-dose temozolomide treatment- case study and review of literature.
Topics: Antineoplastic Agents, Alkylating; Bone Marrow; Bone Marrow Diseases; Brain Neoplasms; Cranial Irradiation; Dacarbazine; Dose-Response Relationship, Drug; Female; Fever; Glioblastoma; Humans; Middle Aged; Neutropenia; Severity of Illness Index; Temozolomide; Treatment Outcome | 2007 |
47 trial(s) available for dacarbazine and Neutropenia
| Article | Year |
|---|---|
Brentuximab vedotin plus doxorubicin and dacarbazine in nonbulky limited-stage classical Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neutropenia; Vinblastine | 2023 |
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Immunoconjugates; Immunologic Factors; Male; Middle Aged; Neoplasm Staging; Neutropenia; Survival Rate; Vinblastine; Young Adult | 2018 |
A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Dose-Response Relationship, Drug; Female; Histones; Humans; Hydroxamic Acids; Leukocytes, Mononuclear; Male; Maximum Tolerated Dose; Neutropenia; Promoter Regions, Genetic; Recurrence; Spinal Cord Neoplasms; Temozolomide; Thrombocytopenia; Tumor Suppressor Proteins; Vorinostat | 2013 |
Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Immunoconjugates; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Neutropenia; Treatment Outcome; Vinblastine | 2013 |
Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas.
Topics: Adult; Aged; Alanine Transaminase; Anilides; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Astrocytoma; Brain Neoplasms; Chemoradiotherapy; Chemoradiotherapy, Adjuvant; Constipation; Dacarbazine; Diarrhea; Fatigue; Female; Glioblastoma; Humans; Hypertension; L-Lactate Dehydrogenase; Leukopenia; Maintenance Chemotherapy; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neoplasm Grading; Neurosurgical Procedures; Neutropenia; Pyridines; Temozolomide; Thrombocytopenia; Treatment Outcome | 2016 |
Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Cohort Studies; Dacarbazine; Docetaxel; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Neoplasm Staging; Neutropenia; Pulmonary Embolism; Skin Neoplasms; Taxoids; Temozolomide; Treatment Outcome | 2009 |
A phase I study of extended dosing with lomeguatrib with temozolomide in patients with advanced melanoma.
Topics: Aged; Aged, 80 and over; Anemia; Antineoplastic Agents; Child; Dacarbazine; Dose-Response Relationship, Drug; Female; Humans; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neutropenia; Patient Selection; Purines; Skin Neoplasms; Temozolomide; Thrombocytopenia | 2009 |
Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Camptothecin; Child; Child, Preschool; Colitis; Dacarbazine; Diarrhea; Female; Humans; Irinotecan; Male; Neutropenia; Pneumonia; Recurrence; Remission Induction; Retrospective Studies; Sarcoma, Ewing; Temozolomide; Thrombocytopenia; Young Adult | 2009 |
Phase I study of vandetanib with radiotherapy and temozolomide for newly diagnosed glioblastoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Diverticulitis; Drug Administration Schedule; ErbB Receptors; Female; Gastrointestinal Hemorrhage; Glioblastoma; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Piperidines; Quinazolines; Temozolomide; Thrombocytopenia; Vascular Endothelial Growth Factor Receptor-2 | 2010 |
A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Administration Schedule; Female; Humans; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Neoplasms; Neutropenia; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Thrombocytopenia | 2011 |
Treatment of Hodgkin lymphoma with adriamycin, bleomycin, vinblastine and dacarbazine without routine granulocyte-colony stimulating factor support does not increase the risk of febrile neutropenia: a prospective cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cost-Benefit Analysis; Dacarbazine; Doxorubicin; Female; Fever; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Risk Factors; Treatment Outcome; Vinblastine; Young Adult | 2012 |
Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy; Chemotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; Dose Fractionation, Radiation; Drug Administration Schedule; Female; Glioblastoma; Humans; Karnofsky Performance Status; Male; Neutropenia; Temozolomide; Thrombocytopenia | 2012 |
Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocyte Subsets; Bleomycin; Clone Cells; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Epstein-Barr Virus Infections; Fatigue; Female; Gastrointestinal Diseases; Herpesvirus 4, Human; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lung Diseases; Male; Middle Aged; Neutropenia; Remission Induction; Rituximab; Survival Rate; Vinblastine; Young Adult | 2012 |
Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Benzamides; Brain Neoplasms; Cohort Studies; Dacarbazine; Diarrhea; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Hydroxyurea; Imatinib Mesylate; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Oligodendroglioma; Piperazines; Pyrimidines; Temozolomide; Thrombocytopenia; Treatment Outcome | 2012 |
Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Alopecia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Fatigue; Female; Gastrointestinal Diseases; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lung Diseases; Male; Middle Aged; Neutropenia; Remission Induction; Rituximab; Survival Rate; Vinblastine; Young Adult | 2012 |
Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Neutropenia; Prednisone; Remission Induction; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine; Young Adult | 2013 |
Temozolomide in combination with interferon alpha-2b in patients with metastatic melanoma: a phase I dose-escalation study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Disease-Free Survival; Female; Humans; Interferon alpha-2; Interferon-alpha; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Neoplasm Staging; Neutropenia; Recombinant Proteins; Skin Neoplasms; Temozolomide; Thrombocytopenia; Treatment Outcome | 2003 |
Pharmacokinetics of temozolomide given three times a day in pediatric and adult patients.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents, Alkylating; Area Under Curve; Brain Neoplasms; Child; Child, Preschool; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Half-Life; Humans; Linear Models; Male; Metabolic Clearance Rate; Middle Aged; Neutropenia; Temozolomide; Thrombocytopenia | 2003 |
Temozolomide in patients with advanced cancer: phase I and pharmacokinetic study.
Topics: Administration, Oral; Adult; Aged; Alkaline Phosphatase; Alkylating Agents; Area Under Curve; Bilirubin; Capsules; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Half-Life; Humans; Maximum Tolerated Dose; Middle Aged; Neoplasms; Neutropenia; Temozolomide; Thrombocytopenia; Tissue Distribution; Treatment Failure | 2004 |
Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancers.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Liposomes; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Neutropenia; Stomatitis; Temozolomide; Treatment Outcome | 2004 |
Evaluation of temozolomide in patients with myelodysplastic syndrome.
Topics: Aged; Anemia; Antineoplastic Agents, Alkylating; Cardiomyopathies; Dacarbazine; Drug Evaluation; Female; Fever; Humans; Male; Maximum Tolerated Dose; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Temozolomide; Treatment Failure | 2004 |
Temozolomide pharmacodynamics in patients with metastatic melanoma: dna damage and activity of repair enzymes O6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Comet Assay; Dacarbazine; DNA Damage; DNA Methylation; DNA Repair; DNA, Neoplasm; Female; Headache; Humans; Lymphocytes; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neutropenia; O(6)-Methylguanine-DNA Methyltransferase; Poly(ADP-ribose) Polymerases; Temozolomide; Thrombocytopenia; Time Factors; Treatment Outcome | 2005 |
Combined chemoimmunotherapy of metastatic melanoma: a single institution experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Dacarbazine; Female; Humans; Interferon alpha-2; Interferon-alpha; Interleukin-2; Male; Melanoma; Nausea; Neutropenia; Recombinant Proteins; Skin Neoplasms; Survival Analysis; Thrombocytopenia; Vinblastine; Vomiting | 2005 |
Phase II trial of temozolomide in children with recurrent high-grade glioma.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Bone Marrow; Brain Neoplasms; Child; Child, Preschool; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Female; Glioma; Humans; Male; Neoplasm Recurrence, Local; Neutropenia; Temozolomide; Thrombocytopenia; Treatment Outcome | 2006 |
Vinorelbine combined with a protracted course of temozolomide for recurrent brain metastases: a phase I trial.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Dacarbazine; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Lymphopenia; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Temozolomide; Thrombocytopenia; Treatment Outcome; Vinblastine; Vinorelbine | 2006 |
Pegfilgrastim compared with filgrastim after high-dose melphalan and autologous hematopoietic peripheral blood stem cell transplantation in multiple myeloma patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Humans; Infection Control; Infections; Male; Melphalan; Middle Aged; Multiple Myeloma; Myeloablative Agonists; Neutropenia; Nimustine; Peripheral Blood Stem Cell Transplantation; Polyethylene Glycols; Recombinant Proteins; Recovery of Function; Time Factors; Transplantation, Autologous; Vincristine | 2006 |
A phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Lomustine; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Neutropenia; Temozolomide; Thrombocytopenia; Treatment Failure | 2007 |
Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Gemcitabine; Hodgkin Disease; Humans; Middle Aged; Neutropenia; Patient Selection; Polyethylene Glycols; Salvage Therapy; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vinblastine; Vinorelbine | 2007 |
[Dicarbamin--an effective protector of myelodepression in combined treatment for Hodgkin's disease].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Caproates; Chemotherapy, Adjuvant; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Granulocytes; Hodgkin Disease; Humans; Imidazoles; Infusions, Intravenous; Leukocyte Count; Male; Middle Aged; Neutropenia; Protective Agents; Radiotherapy, Adjuvant; Treatment Outcome; Vinblastine | 2007 |
Multicenter phase II study of chemoimmunotherapy in the treatment of metastatic melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Dacarbazine; Dexamethasone; Diarrhea; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Therapy; Female; Humans; Immunotherapy; Interferon alpha-2; Interferon-alpha; Interleukin-2; Isotretinoin; Magnesium Sulfate; Male; Melanoma; Middle Aged; Neutropenia; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Treatment Outcome; Vinblastine | 2008 |
Randomized phase III trial of vinblastine, bleomycin, and cis-dichlorodiammine-platinum versus dacarbazine in malignant melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Dacarbazine; Female; Humans; Male; Melanoma; Middle Aged; Mouth Diseases; Neutropenia; Random Allocation; Sepsis; Skin Neoplasms; Thrombocytopenia; Vinblastine | 1984 |
The role of granulocyte colony-stimulating factor (filgrastim) in maintaining dose intensity during conventional-dose chemotherapy with ABVD in Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Infection Control; Male; Middle Aged; Neutropenia; Recombinant Proteins; Treatment Outcome; Vinblastine; Vincristine | 1994 |
High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Resistance; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Kidney; Male; Mesna; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Sarcoma | 1995 |
Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Double-Blind Method; Doxorubicin; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematuria; Hemoglobins; Humans; Ifosfamide; Injections, Subcutaneous; Length of Stay; Lenograstim; Leukocyte Count; Male; Mesna; Middle Aged; Nausea; Neutropenia; Platelet Count; Recombinant Proteins; Regression Analysis; Sarcoma; Soft Tissue Neoplasms; Stomatitis | 1995 |
Sequential therapy with dacarbazine and carmustine: a phase I study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Dacarbazine; Drug Administration Schedule; Female; Humans; Male; Methyltransferases; Middle Aged; Monocytes; Neoplasms; Neutropenia; O(6)-Methylguanine-DNA Methyltransferase; Thrombocytopenia | 1994 |
Sequential administration of varying doses of dacarbazine and fotemustine in advanced malignant melanoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Melanoma; Middle Aged; Neutropenia; Nitrosourea Compounds; Organophosphorus Compounds; Respiratory Distress Syndrome; Thrombocytopenia | 1993 |
Accelerated epirubicin-ifosfamide-dacarbazine regimen in patients with adult soft tissue sarcomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Staging; Neutropenia; Sarcoma; Treatment Outcome | 1996 |
[The whole dose at once?].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Leukocytosis; Male; Middle Aged; Neutropenia; Premedication; Recombinant Proteins; Vinblastine | 1996 |
High-dose-intensity combination chemotherapy for advanced sarcomas: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematologic Tests; Humans; Ifosfamide; Infusions, Intravenous; Male; Mesna; Middle Aged; Neutropenia; Pilot Projects; Recombinant Proteins; Sarcoma | 1998 |
A Phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignancies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nausea; Neoplasm Staging; Neoplasms; Neutropenia; Temozolomide; Treatment Outcome; Vomiting | 1999 |
Phase I and pharmacokinetic study of temozolomide on a daily-for-5-days schedule in patients with advanced solid malignancies.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Alkylating; Area Under Curve; Dacarbazine; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Neutropenia; Temozolomide | 1999 |
Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Dose-Response Relationship, Drug; Double-Blind Method; Doxorubicin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hodgkin Disease; Humans; Injections, Subcutaneous; Male; Mechlorethamine; Middle Aged; Neutropenia; Prednisone; Procarbazine; Prospective Studies; Recombinant Proteins; Vinblastine; Vincristine | 2000 |
A phase II study of biochemotherapy for the treatment of metastatic malignant melanoma.
Topics: Abdominal Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Colorado; Combined Modality Therapy; Dacarbazine; Female; Follow-Up Studies; Humans; Hypotension; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Interleukin-2; Life Tables; Liver Neoplasms; Lung Neoplasms; Male; Melanoma; Middle Aged; Neutropenia; Recombinant Proteins; Remission Induction; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine | 2000 |
Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology Group.
Topics: Adult; Aged; Anemia; Antigens, CD; Antigens, Neoplasm; Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; CD146 Antigen; Cisplatin; Dacarbazine; Female; Fever; Follow-Up Studies; Humans; Interferon-alpha; Male; MART-1 Antigen; Melanoma; Melanoma-Specific Antigens; Membrane Glycoproteins; Middle Aged; Monophenol Monooxygenase; Nausea; Neoplasm Proteins; Neural Cell Adhesion Molecules; Neutropenia; Nitrosourea Compounds; Organophosphorus Compounds; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vomiting | 2000 |
Temozolomide: the effect of once- and twice-a-day dosing on tumor tissue levels of the DNA repair protein O(6)-alkylguanine-DNA-alkyltransferase.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Area Under Curve; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Neoplasms; Neutropenia; O(6)-Methylguanine-DNA Methyltransferase; Temozolomide; Thrombocytopenia; Time Factors; Treatment Outcome; Tumor Cells, Cultured | 2001 |
Temozolomide in combination with docetaxel in patients with advanced melanoma: a phase II study of the Hellenic Cooperative Oncology Group.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Disease-Free Survival; Docetaxel; Female; Humans; Infusions, Intravenous; Male; Melanoma; Middle Aged; Neutropenia; Paclitaxel; Skin Neoplasms; Taxoids; Temozolomide; Thrombocytopenia | 2002 |
Vinblastin-carboplatin for metastatic cutaneous melanoma as first-line chemotherapy and in dacarbazine failures: a single-center study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dacarbazine; Disease Progression; Drug Resistance, Neoplasm; Female; Humans; Male; Melanoma; Middle Aged; Neutropenia; Salvage Therapy; Skin Neoplasms; Thrombocytopenia; Treatment Outcome; Vinblastine | 2001 |
30 other study(ies) available for dacarbazine and Neutropenia
| Article | Year |
|---|---|
Irinotecan plus temozolomide in relapsed Ewing sarcoma: an integrated analysis of retrospective studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Dacarbazine; Humans; Irinotecan; Neoplasm Recurrence, Local; Neutropenia; Retrospective Studies; Sarcoma, Ewing; Temozolomide | 2022 |
Safety of temozolomide use in adult patients with renal dysfunction.
Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Glioma; Humans; Kidney Diseases; Lymphopenia; Methylhydrazines; Neutropenia; Temozolomide; Thrombocytopenia | 2022 |
Evaluation of neutropenia-related outcomes in Hodgkin's lymphoma patients with moderate or severe neutropenia who received ABVD chemotherapy without using granulocyte-colony stimulating factor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Male; Middle Aged; Neutropenia; Vinblastine | 2020 |
Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Neoplasm Staging; Neutropenia; Peripheral Nervous System Diseases; Vinblastine | 2022 |
Prognostic importance of temozolomide-induced neutropenia in glioblastoma, IDH-wildtype patients.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Female; Glioblastoma; Humans; Isocitrate Dehydrogenase; Karnofsky Performance Status; Male; Middle Aged; Neutropenia; Prognosis; Proportional Hazards Models; Retrospective Studies; Temozolomide; Treatment Outcome | 2018 |
Factors predicting temozolomide induced clinically significant acute hematologic toxicity in patients with high-grade gliomas: a clinical audit.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cohort Studies; Community-Acquired Infections; Dacarbazine; Female; Glioma; Hematologic Diseases; Humans; Logistic Models; Male; Middle Aged; Neutropenia; Predictive Value of Tests; Temozolomide; Thrombocytopenia | 2013 |
A retrospective study of capecitabine/temozolomide (CAPTEM) regimen in the treatment of metastatic pancreatic neuroendocrine tumors (pNETs) after failing previous therapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Dacarbazine; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Fatigue; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Neutropenia; Pancreatic Neoplasms; Remission Induction; Retrospective Studies; Temozolomide; Thrombocytopenia; Time Factors; Treatment Outcome | 2013 |
Clinical outcomes of patients with newly diagnosed primary central nervous system lymphoma are comparable on treatment with high-dose methotrexate plus temozolomide and with high-dose methotrexate plus cytarabine: a single-institution experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Dacarbazine; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neutropenia; Remission Induction; Temozolomide; Thrombocytopenia; Treatment Outcome; Young Adult | 2014 |
Craniospinal irradiation with concomitant and adjuvant temozolomide--a feasibility assessment of toxicity in patients with glioblastoma with a PNET component.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy; Chemotherapy, Adjuvant; Child; Craniospinal Irradiation; Dacarbazine; Dose Fractionation, Radiation; Feasibility Studies; Female; Follow-Up Studies; Glioblastoma; Humans; Lymphopenia; Male; Neoplasm Staging; Neuroectodermal Tumors, Primitive; Neutropenia; Prognosis; Survival Rate; Temozolomide; Thrombocytopenia; Young Adult | 2016 |
Isolated neutropenia during ABVD chemotherapy for Hodgkin lymphoma does not require growth factor support.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoprevention; Cost-Benefit Analysis; Dacarbazine; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Incidence; Leukocyte Count; Male; Middle Aged; Neutropenia; Retrospective Studies; Sepsis; Vinblastine | 2008 |
Risk analysis of severe myelotoxicity with temozolomide: the effects of clinical and genetic factors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Brain Neoplasms; Dacarbazine; Female; Glioma; Glutathione S-Transferase pi; Humans; Male; Middle Aged; NAD(P)H Dehydrogenase (Quinone); Neoplasm Staging; Neutropenia; O(6)-Methylguanine-DNA Methyltransferase; Polymorphism, Single Nucleotide; Prognosis; Retrospective Studies; Risk Factors; Temozolomide; Thrombocytopenia; Young Adult | 2009 |
Management of temozolomide toxicity by nurse practitioners in neuro-oncology.
Topics: Analysis of Variance; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chi-Square Distribution; Dacarbazine; Drug Administration Schedule; Drug Monitoring; Glioma; Humans; Lymphopenia; Nausea; Netherlands; Neutropenia; Nurse Practitioners; Nurse's Role; Nursing Evaluation Research; Oncology Nursing; Prospective Studies; Statistics, Nonparametric; Temozolomide; Thrombocytopenia; Treatment Outcome; Vomiting | 2009 |
Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colony-Stimulating Factors; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Vinblastine | 2010 |
[Nimotuzumab in combination with chemotherapy for patients with malignant gliomas].
Topics: Adolescent; Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Child; Cisplatin; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Glioma; Humans; Infusions, Intravenous; Male; Nausea; Neutropenia; Nimustine; Temozolomide; Teniposide; Thrombocytopenia; Young Adult | 2011 |
Intermittent granulocyte colony-stimulating factor maintains dose intensity after ABVD therapy complicated by neutropenia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Retrospective Studies; Vinblastine; Young Adult | 2012 |
Treatment-related toxicities in tumor-bearing cats treated with temozolomide alone or in combination with doxorubicin: a pilot assessment.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cat Diseases; Cats; Dacarbazine; Doxorubicin; Drug Administration Schedule; Maximum Tolerated Dose; Neoplasms; Neutropenia; Pilot Projects; Retrospective Studies; Stomatitis; Temozolomide | 2012 |
Severe Chlamydia pneumoniae infection in a patient with mild neutropenia during treatment of Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aza Compounds; Bleomycin; Chlamydophila Infections; Chlamydophila pneumoniae; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Fluoroquinolones; Hodgkin Disease; Humans; Imipenem; Immunocompromised Host; Moxifloxacin; Neutropenia; Pneumonia, Bacterial; Quinolines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Vincristine | 2004 |
High-dose idarubicin, busulphan and melphalan for autologous stem cell transplantation in multiple myeloma responsive to DAV chemotherapy: comparison with a historical control.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Dacarbazine; Female; Graft Survival; Humans; Idarubicin; Infections; Male; Melphalan; Middle Aged; Mucositis; Multiple Myeloma; Neutropenia; Nimustine; Peripheral Blood Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous; Vincristine | 2006 |
Neutropenia and febrile neutropenia in patients with Hodgkin's lymphoma treated with doxorubicin (Adriamycin), bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fever; Hodgkin Disease; Humans; Male; Neutropenia; Time Factors; Treatment Outcome; Vinblastine | 2006 |
[Effect of modified MAID regimen for patients with advanced soft tissue sarcoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Female; Fibrosarcoma; Follow-Up Studies; Humans; Ifosfamide; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Staging; Neutropenia; Remission Induction; Rhabdomyosarcoma; Sarcoma, Synovial; Soft Tissue Neoplasms; Survival Rate; Thrombocytopenia; Young Adult | 2006 |
Safety and efficacy of once-per-cycle pegfilgrastim in support of ABVD chemotherapy in patients with Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Diseases; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Male; Middle Aged; Neutropenia; Pain; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Treatment Outcome; Vinblastine | 2006 |
The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas.
Topics: Adult; Aged; Anemia; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Female; Glioma; Humans; Male; Middle Aged; Neutropenia; Retrospective Studies; Temozolomide; Thrombocytopenia; Treatment Outcome | 2007 |
[Individualized chemotherapy based on drug sensitivity and resistance assay and MGMT protein expression for patients with malignant glioma--analysis of 42 cases].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Cisplatin; Dacarbazine; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Glioma; Humans; Male; Middle Aged; Nausea; Neutropenia; O(6)-Methylguanine-DNA Methyltransferase; Remission Induction; Temozolomide; Young Adult | 2006 |
[Temozolomide, an oral chemotherapeutic agent with potential severe toxicity].
Topics: Antineoplastic Agents, Alkylating; Dacarbazine; Fatal Outcome; Female; Fever; Glioblastoma; Humans; Male; Middle Aged; Neutropenia; Temozolomide | 2007 |
Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia: results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemia.
Topics: Adolescent; Adult; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Cytokines; Dacarbazine; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-2; Interleukin-6; Interleukin-8; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neutropenia; Nimustine; Prospective Studies; Sialoglycoproteins; Tumor Necrosis Factor-alpha; Vincristine | 1995 |
Intermittent G-CSF to maintain dose intensity of chemotherapy for Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Granulocyte Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Hodgkin Disease; Humans; Neutropenia; Vinblastine; Vincristine | 1995 |
Chemotherapy for desmoid tumors in association with familial adenomatous polyposis.
Topics: Adenomatous Polyposis Coli; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dacarbazine; Doxorubicin; Epistaxis; Female; Fever; Fibromatosis, Abdominal; Follow-Up Studies; Humans; Male; Middle Aged; Neutropenia; Remission Induction; Subclavian Vein; Thrombosis; Tomography, X-Ray Computed | 1997 |
G-CSF (filgrastim) as an adjunct to MOPP/ABVD therapy in Hodgkin's disease.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Filgrastim; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematinics; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nervous System; Neutropenia; Prednisone; Procarbazine; Recombinant Proteins; Remission Induction; Retrospective Studies; Survival Rate; Thrombocytopenia; Treatment Outcome; Vinblastine; Vincristine | 1997 |
Association between alopecia and response to aggressive chemotherapy in patients with Hodgkin's disease.
Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neutropenia; Prednisone; Procarbazine; Vinblastine; Vincristine | 1999 |
Population pharmacokinetics of temozolomide in cancer patients.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Body Fluid Compartments; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dacarbazine; Female; Humans; Male; Middle Aged; Models, Biological; Neoplasms; Neutropenia; Temozolomide; Thrombocytopenia | 2000 |